This Pet Stock Is Down 40% This Year Despite Growing Free Cash Flow by 24% in 2025
Chewy (CHWY) shares are down over 40% year to date despite fiscal 2025 free cash flow rising 24%, the article says. Autoship subscription sales rose to 83% of revenue (from 76% two years earlier), with subscriber sales up 12% vs. total revenue up 6%. The stock decline reflects concerns about discretionary pet spending, price competition, and potential AI disruption to ads, while Chewy expands clinics via Modern Animal (29 sites, 47 total) and targets further margin gains.
How this was made
The 30-second read
Why it matters
The market is weighing improving free cash flow and EBITDA margin against persistent concerns: discretionary pet spending softness, retailer price competition, and the possibility that AI shopping agents erode Chewy’s higher-margin advertising revenue.
Market read
Trading focus is on whether margin/FCF improvements can offset price-war and AI-ad disruption fears that have driven the stock’s large YTD decline.
What to watch
Execution risk around clinic build-out and Modern Animal integration could swing margins; also, AI-efficiency savings are forecasted, so timing vs. expectations matters.
Background
Chewy’s Autoship subscription mix is rising, but the stock is trading as if near-term demand and competitive pricing will overwhelm profitability gains.
Ticker impact
Chewy shares are down 40% YTD while it reports 24% free-cash-flow growth and guides for further margin expansion, alongside AI/ad-business disruption risk.
Near-term volatility likely remains elevated; upside bias if investors focus on margin/FCF trajectory and clinic/private-brand execution, downside risk if price-war fears or AI threat intensify.
The article ties the drawdown to competitive and AI concerns, while also citing improving EBITDA margin and accretive clinic expansion—two offsetting forces that typically drive choppy tape action rather than a clean trend.
Market effects
Pet retail/CPG-adjacent players may face read-across on margin sensitivity to price competition and potential e-commerce/AI shopping-agent disintermediation.
Primarily US consumer discretionary sentiment; no specific regional catalyst beyond competition and ad-market concerns.
Limited—story is company-specific to Chewy’s US model and competitive set.
Counterpoint
If Autoship penetration (83% of revenue) continues to grow and margin targets are met, the stock’s drawdown may be overdone versus improving cash generation.
Key entities
- companyChewy
Autoship-led revenue mix, improving free cash flow and EBITDA margin, plus clinic expansion and AI-driven efficiency savings guidance.
- companyModern Animal
Acquired by Chewy to add 29 clinic locations; expected to be accretive within a year.
